When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
ALPMY - Astellas teams up with ReForm in alternate dosing of biologics
Astellas Pharma Inc. ADR
Astellas Pharma (OTCPK:ALPMY+0.9%) will collaborate with Woburn, MA-based ReForm Biologics on reformulating its pipeline of biologic therapies to allow for alternative dosing, specifically subcutaneous injection, more efficient manufacturing and longer product life cycles.
More news on: Astellas Pharma, Inc. ADR, Astellas Pharma, Inc., Healthcare stocks news, Stocks on the move,